- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 103/40 - Actinides
Patent holdings for IPC class A61K 103/40
Total number of patents in this class: 63
10-year publication summary
|
0
|
2
|
1
|
2
|
3
|
0
|
5
|
5
|
7
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Algeta ASA | 15 |
3 |
| Memorial Sloan-Kettering Cancer Center | 1945 |
3 |
| Novartis Pharma AG | 97 |
2 |
| Actinium Pharmaceuticals Inc. | 138 |
2 |
| Advanced Accelerator Applications USA, Inc. | 6 |
2 |
| Bayer AS | 37 |
2 |
| Ecole Nationale Superieure de Chimie de Montpellier | 205 |
2 |
| Helmholtz-Zentrum Dresden-Rossendorf e.V. | 132 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2886 |
2 |
| Institut Regional du Cancer de Montpellier | 98 |
2 |
| Nihon Medi-physics Co., Ltd. | 180 |
2 |
| Universite de Montpellier | 997 |
2 |
| Advanced Accelerator Applications International S.A. | 47 |
2 |
| Centre National de La Recherche Scientifique (cnrs) | 3103 |
2 |
| Mariana Oncology Inc. | 15 |
2 |
| Aken Medical | 2 |
2 |
| Novartis AG | 10730 |
1 |
| AstraZeneca UK Limited | 633 |
1 |
| Bayer Pharma AG | 1054 |
1 |
| Assistance Publique Hopitaux de Marseille | 121 |
1 |
| Other owners | 25 |